EP2318539A2 - Method for purifying nucleic acids from microorganisms present in liquid samples - Google Patents
Method for purifying nucleic acids from microorganisms present in liquid samplesInfo
- Publication number
- EP2318539A2 EP2318539A2 EP09784273A EP09784273A EP2318539A2 EP 2318539 A2 EP2318539 A2 EP 2318539A2 EP 09784273 A EP09784273 A EP 09784273A EP 09784273 A EP09784273 A EP 09784273A EP 2318539 A2 EP2318539 A2 EP 2318539A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- microorganisms
- nucleic acids
- active surface
- sample
- capture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 105
- 238000000034 method Methods 0.000 title claims abstract description 79
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 77
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 77
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 77
- 239000007788 liquid Substances 0.000 title claims abstract description 38
- 230000009089 cytolysis Effects 0.000 claims abstract description 30
- 238000011282 treatment Methods 0.000 claims abstract description 11
- 238000011065 in-situ storage Methods 0.000 claims abstract description 6
- 239000011324 bead Substances 0.000 claims description 34
- 238000000746 purification Methods 0.000 claims description 29
- 238000010828 elution Methods 0.000 claims description 20
- 238000005349 anion exchange Methods 0.000 claims description 18
- 238000001179 sorption measurement Methods 0.000 claims description 12
- 239000011347 resin Substances 0.000 claims description 11
- 229920005989 resin Polymers 0.000 claims description 11
- 238000004458 analytical method Methods 0.000 claims description 10
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 125000003277 amino group Chemical group 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 6
- 230000008030 elimination Effects 0.000 claims description 5
- 238000003379 elimination reaction Methods 0.000 claims description 5
- 108010039918 Polylysine Proteins 0.000 claims description 4
- 230000006862 enzymatic digestion Effects 0.000 claims description 4
- 229920000656 polylysine Polymers 0.000 claims description 4
- 230000035939 shock Effects 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 claims description 3
- 238000005299 abrasion Methods 0.000 claims description 2
- 230000009471 action Effects 0.000 claims description 2
- 238000004520 electroporation Methods 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 230000002934 lysing effect Effects 0.000 claims description 2
- 230000003204 osmotic effect Effects 0.000 claims description 2
- 239000004417 polycarbonate Substances 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims description 2
- 238000000527 sonication Methods 0.000 claims description 2
- 125000001302 tertiary amino group Chemical group 0.000 claims 2
- 230000001172 regenerating effect Effects 0.000 claims 1
- 238000005342 ion exchange Methods 0.000 abstract description 12
- 230000036541 health Effects 0.000 abstract description 4
- 244000000010 microbial pathogen Species 0.000 abstract description 4
- 239000000523 sample Substances 0.000 description 70
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 42
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 39
- 239000000243 solution Substances 0.000 description 38
- 230000008569 process Effects 0.000 description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 239000011780 sodium chloride Substances 0.000 description 20
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 18
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 14
- 238000001514 detection method Methods 0.000 description 14
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
- 238000011534 incubation Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 150000001450 anions Chemical class 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 7
- 238000011109 contamination Methods 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 229910001868 water Inorganic materials 0.000 description 7
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 230000005291 magnetic effect Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000002906 microbiologic effect Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000008929 regeneration Effects 0.000 description 6
- 238000011069 regeneration method Methods 0.000 description 6
- 229920002873 Polyethylenimine Polymers 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 238000000018 DNA microarray Methods 0.000 description 4
- 108010067770 Endopeptidase K Proteins 0.000 description 4
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
- 102000016943 Muramidase Human genes 0.000 description 4
- 108010014251 Muramidase Proteins 0.000 description 4
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 4
- 125000000129 anionic group Chemical group 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000005341 cation exchange Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 238000002032 lab-on-a-chip Methods 0.000 description 4
- 239000004325 lysozyme Substances 0.000 description 4
- 229960000274 lysozyme Drugs 0.000 description 4
- 235000010335 lysozyme Nutrition 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 230000004544 DNA amplification Effects 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 229960004198 guanidine Drugs 0.000 description 3
- 239000008235 industrial water Substances 0.000 description 3
- 229920003303 ion-exchange polymer Polymers 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000005464 sample preparation method Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000701109 Human adenovirus 2 Species 0.000 description 2
- 108091030071 RNAI Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000014670 detection of bacterium Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000005298 paramagnetic effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000011895 specific detection Methods 0.000 description 2
- 150000003512 tertiary amines Chemical group 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000002525 ultrasonication Methods 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 108091032955 Bacterial small RNA Proteins 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical group 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 238000010960 commercial process Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 244000309711 non-enveloped viruses Species 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000002743 phosphorus functional group Chemical group 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004094 preconcentration Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000003335 secondary amines Chemical group 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 229960004029 silicic acid Drugs 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- -1 sulphonic groups Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000033772 system development Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Definitions
- the invention relates to the field of global detection of pathogenic microorganisms possibly poorly represented in the samples to be analyzed and whose impact on public health, whether human or animal, can be considerable.
- the present invention more specifically relates to a method of treating liquid samples for the detection of possible pathogenic microorganisms in very small quantities. More specifically, this process consists of a generic step of capture and concentration of microorganisms, followed by in situ lysis of microorganisms and capture of the nucleic acids released during lysis. The implementation of this method makes it possible to obtain an extremely concentrated and purified nucleic acid solution. This method is further adapted for continuous processing of liquid samples.
- the samples to be treated may be of complex biological and physicochemical composition.
- the characteristics that make the analysis of the sample difficult lie mainly in the variability of total biomass, ionic strength, pH, the presence of colloids, small molecules of decomposition of organic matter, or artificial chemical substances. in said sample.
- the samples to be analyzed contain a ubiquitous microbiological flora more or less concentrated, with no real impact on public health or the scientific studies carried out. This is for example the case of water samples (industrial, environmental) and conforms they may contain, these bacteria being pathogenic only at high concentrations; this is also valid for samples obtained from air, sludge or stool.
- the search for microorganisms with little or no concentration in a sample may be necessary, for example in the case of the detection of pathogens likely to colonize drinking water circuits, industrial or environmental waters or air. This is most often viruses, bacteria, protozoa, amoebae, fungi, yeasts, algae, worms ... This detection is essential since these pathogens can then be responsible for serious diseases including cholera, legionella, typhoid , in which one can observe the following symptoms: diarrhea, dysentery, gastroenteritis.
- microbiological monitoring makes it possible to initiate disinfection or treatment of water or industrial installations before discharge into the environment, and thus to comply with the regulatory microbiological standards.
- the reference technique is based on identification and enumeration of microorganisms by culture on different selective media. This is a technique that takes a long time to implement, often hours and which can be biased by both commensal flora but also by the presence of microorganisms stunted or even viable but not culturable and yet pathogenic. In addition, this method may not take into account slow growing microorganisms.
- Another technique allows rapid quantification of the total microbial population by measurement of enzymatic activity. This technique has the advantage of taking into account viable but non-culturable bacteria. On the other hand, it does not allow the specific identification of microorganisms.
- the filters or pellets generated are respectively often saturated or compact, contain many molecules and particles that are difficult to characterize, and which are known to interfere strongly with biological methods of analysis, such as antigen-antibody interactions or gene amplifications. It is therefore often necessary to dilute the samples very strongly to avoid inhibitions of the detection reactions, and to avoid false negative results.
- results obtained therefore correspond to instantaneous images of a state of contamination of a particular environment. They can not take into account the variability of contamination related to the environment.
- Liu et al. describe a biochip for the detection of bacteria in which the following steps are performed: the immunomagnetic capture of the target bacteria; pre-concentration of bacteria and their purification; lysis of bacteria; PCR amplification of the nucleic acids obtained and detection based on electrochemical DNA chips (Liu et al Anal Chem (2004) 76, 1824-1831).
- this device allows only a specific detection, targeting a particular bacterium.
- Cheng et al. disclose a biochip for the detection of bacteria in blood samples having a fluid chamber in which a dielectrophoretic separation of bacterial cells and blood cells is performed; electronic lysis (by application of a series of electrical pulses) of the captured bacteria; digestion of proteins with proteinase K; and an analysis of RNA and DNA released with DNA chips.
- the dielectrophoretic separation step allows the capture of only a small fraction of the bacteria thus limiting the applications of this device; in particular, it is not suitable for processing samples that may contain small amounts of microorganisms (Cheng et al., Nature Biotechnology (1998) 16, 541-546).
- PEI polyethyleneimine
- nucleic acid DNA and RNA
- the advantages of the described method and device are: generic capture; a high degree of concentration of microorganisms and possibly nucleic acids; a high degree of purification of microorganisms and possibly nucleic acids; simple integration into automated systems. More specifically, the present invention relates to a method for treating a liquid sample for analysis of the nucleic acids of the microorganisms likely to be contained in said sample consisting of:
- step (C) adsorbing the nucleic acids released in step (B) onto a second anion exchange active surface.
- the lysis step (B) is carried out in situ while said microorganisms are adsorbed on said first active surface and / or said first active surface is anion exchange surface and said second active surface is the same as said first active surface.
- 'Liquid sample means an industrial water withdrawal (eg from the cooling circuit), environmental water, or drinking water intended for human or animal consumption and, by extension, any sample in which the element or elements to be detected are in solution or in suspension.
- This sample may itself have been obtained from a sample or other sample containing the elements of interest, for example a body fluid, a sample of air, obtained by physical and / or chemical treatment, and / or biological according to any method adaptable by the skilled person.
- these are aqueous or high aqueous component samples.
- the samples are preferably made under conditions of great cleanliness with sterile material.
- the liquid samples are prepared according to techniques known to those skilled in the art (see in particular the publication of Stachowiak JC, Shugard EE, BP Mosier, Renzi RF, Caton PF Ferko SM, Van de Vreugde JL, Yee DD, Haroldsen BL, VanderBoot VA Autonomous microfluidic sample preparation system for protein profile-based detection of aerosolized bacterial cells and spores Anal Chem 2007 Aug. 1; 79 (15): 5763 -70).
- the volume of the liquid samples is between 1 and 100 ml, preferably it is 10 ml.
- the liquid sample is such:
- Micro-organisms means enveloped or non-enveloped viruses, Gram-positive and negative vegetative bacteria, spore-forming bacteria, protozoa, microscopic fungi and yeasts, microplankton, pollens, animal cells and the plant cells that we want to capture, and / or concentrate, and / or purify, and / or detect.
- active ion exchange surface is meant any ion exchange surfaces (anions or cations), more or less strong, allowing adsorption of microorganisms, or their constituents up to the molecular level.
- the active surface is selected from strong ion exchange resins.
- the active surface will be an anion exchange surface or anionic resin.
- anion exchange surface or anionic resin is meant a surface carrying charged chemical functions whatever the pH conditions. This is for example the case of quaternary amines, all of whose bonds are engaged with radicals other than protons.
- PEI polyethyleneimine
- DEAE diethylaminoethyl
- a strong anion exchange surface is all the stronger as the proportion of quaternary amine is important.
- the anionic resins (anion exchange) can be classified according to Table I below.
- Cationic resins (cation exchange) can be classified according to Table II below.
- the anion or cation exchange surfaces may be fixed or mobile, arranged within a device for extraction and purification of nucleic acids of microorganisms, they are chosen from charged polymers whose branching with a carbon chain allows the reinforcement of the load; in particular, they are selected from the group consisting of resins having groups selected from quaternary amino groups, tertiary amine groups, secondary amine groups, primary amino groups, sulphonic groups, phosphorus groups, carboxymethyl groups or carboxylic acid; or the hydroxylapatite, Di-ethyl-amino-ethyl (DEAE), poly-lysine and poly-ethylene-lmine (PEI) resins.
- DEAE Di-ethyl-amino-ethyl
- PEI poly-ethylene-lmine
- ion exchange surfaces in particular anions, described above allow the generic adsorption of microorganisms, and can be adapted to a very broad spectrum of applications.
- the elimination of the liquid medium initially containing the microorganisms to be sought can be easily achieved without risking picking up microorganisms from the surface.
- the elimination of the liquid medium allows the concentration of the microorganisms captured before lysis.
- the volume of the sample can be reduced to a volume of between 1 and 10 ⁇ l.
- ion exchange surfaces useful for carrying out the method of the invention resist the physical, chemical or enzymatic processes of opening microorganisms to release their nucleic acids.
- these surfaces also allow the purification and concentration of the nucleic acids in a solvent compatible with the biological reactions, in very low volumes, from 1 to 10 ⁇ l.
- anion or cation exchange surfaces advantageously rest on a support material enabling the active groups to be received vis-à-vis the process described, and whose integrity is not or very little altered by the opening treatments of the microorganisms.
- a support material enabling the active groups to be received vis-à-vis the process described, and whose integrity is not or very little altered by the opening treatments of the microorganisms.
- silica and polycarbonate By way of example and without limitation, mention may be made of silica and polycarbonate.
- the surfaces and their support can be either mobile, as in the case of magnetic beads for example, or fixed, as in the case of a lab on a chip.
- Lab-on-a-chip means any fluidic and / or microfluidic device comprising adequately sized, structured and functionalised sample passage zones (by surface modification or filling of functional reagents) completely or partially automated or not automated.
- the active surface and its support are movable in the form of balls, they are added to the whole of the liquid sample and are distributed in such a way that they behave like a net, with the smallest mesh size distance between the balls.
- the device must then be able to collect the beads to retain the captured elements (microorganisms, nucleic acids) and concentrate the sample.
- the device When the medium is fixed, there is no risk of aggregation.
- the device must, however, be sized and designed to allow effective capture of microorganisms for example by promoting the probabilities of meeting active surface - sample.
- the sample is brought into contact with the active surfaces in fractions, at speeds depending on the flow rate applied to the device.
- step (A) of capture of the microorganisms contained in a liquid sample is carried out on an active surface, ie anion exchange.
- the active surface is an anion exchange surface selected from quaternary amino groups, tertiary amine groups, secondary amino groups, primary amino groups; or the resins hydroxylapatite, Di-Ethyl-Amino-Ethyl (DEAE), poly-Lysine and Poly-Ethylene Imine (PEI).
- Step (A) can be carried out with an ion exchange surface such that:
- the active surface per unit volume of liquid sample that may be contained in the chamber in which the capture of the microorganisms is carried out is between 1 and 200 m 2 / l of sample, preferably between 9 and 100 m 2 / l ; the distance between the active surface and the elements to be captured is of the order of 10 to 100 micrometers, preferably 10 micrometers;
- the time for contacting the liquid sample with the active surface is of the order of 30 seconds to 10 minutes, preferably 10 minutes;
- the contacting temperature is between 4 ° C. and 40 ° C., preferably 25 ° C. ⁇ 5 ° C.
- an optional concentration step (A ') is advantageously carried out by the physical separation of the capture surface (fixed support or mobile support) and the liquid solvent.
- the active surface is mobile carried by magnetic beads
- the opening step (B) (lysis) of the microorganisms allowing the release of the nucleic acids is carried out directly on the microorganisms retained on the active surface; it can be carried out by any method known to those skilled in the art, in particular by sonication, abrasion by glass beads, enzymatic digestion, thermal shock, osmotic shock, light irradiation, electroporation, microwave action, etc. depending on the sample considered and the intended application following this step.
- An advantage of this method is to perform the lysis in situ, ie while the microorganisms are adsorbed on the active surface. To omit a stage of elution of microorganisms is advantageous; in fact, the fewer stages of the process, the more fluid transfers, potential contamination factors and loss of material are avoided; in addition, this makes the process more easily automatable.
- the step (B) of lyse microorganisms directly in the presence of the active surface can be achieved by different chemical and / or physical and / or biological and not altering, or very little, the structural properties and functional surfaces and / or their supports.
- the lysis can be carried out by enzymatic digestion with lysozyme alone or with lysozyme and then proteinase K.
- Preferential digestion with lysozyme followed by proteinase K will be preferable under the respective lysis conditions in a medium of composition: Tris-HCl at 50 mM, NaCl at 50 mM, EDTA at 5 mM, pH 7.5, for 10 minutes at room temperature, then in a medium of composition: Tris-HCl 10 mM, EDTA at 2 mM, pH 8.0 or 4M NaCl, 10 mM Tris-HCl, 2 mM EDTA, 0.1% sarcosyl, pH 9.0, for 15 minutes at 70 ° C.
- step (B) is carried out by ultrasonication of the sample under optimum conditions as a function of the geometry of the chamber containing the sample and whether the support of the active surface is fixed or mobile.
- the present process may comprise an additional step (A1), which is intercalated between step (A) and step (B), for purification of the microorganisms.
- This purification step (A1) corresponds to a washing of the surface on which the microorganisms are fixed with a solution chosen so as not to disturb the attachment of the microorganisms to the exchange surface.
- a salt solution may be employed, the characteristics of which are dependent on the active surface employed.
- purification is generally meant the elimination of unnecessary or troublesome compounds which have attached to the active surfaces under the same conditions as the microorganisms or nucleic acids of interest released at course of step (B), but whose elution can be achieved by suitable solutions, without the risk of eluting, or at least very partially, said microorganisms and nucleic acids which remain adsorbed on the active surface.
- the optional purification step (A1) may be carried out by incubating the active surface with a washing solution based on salts, preferably having the following composition: 0.8M NaCl, 10 mM Tris-HCl, 15% ethanol % (v / v), pH 8.
- the process according to the invention also comprises a step (C), following step (B), of adsorption of the nucleic acids released by the lysis of said microorganisms.
- the nucleic acids released are, during step (C), either immediately adsorbed on the first active surface that has allowed the capture of microorganisms, or adsorbed on a second electrostatic force anion exchange surface similar to that of step (A).
- a second electrostatic force anion exchange surface similar to that of step (A).
- the same first anion exchange surface is used as the first and second active surfaces.
- a possible step (A2) of elution of the microorganisms of the first active surface can be carried out, following step (A) or step (A1) and preceding step (B), with a solution which promotes the separation of the microorganisms of the first active surface by competition with an ion of the same charge, or by chemical modification of the surface charge density of the balls and / or microorganisms.
- Step (A2) can be carried out by incubating the active surface with a solution of 100 mM sodium hydroxide, containing or not detergents, optionally supplemented by physical methods such as heating, stirring with a vortex or ultrasound.
- the microorganisms contained in the eluate may be isolated from the first active surface to undergo the lysis provided in step (B) or undergo lysis in the presence of the first active surface but without being adsorbed.
- a possible step (A3), following step (A2), of regeneration of the first active surface can also be carried out with a solution of sodium hydroxide (NaOH) so as to continue with another capture cycle in accordance with step (A) for a predetermined number of cycles.
- Regeneration of the active capture surface of the microorganisms can be carried out in the following conditions: incubation of the active surface with a solution of sodium chloride, preferably 100 mM, then its removal or incubation of the active surface with deionized water, and its removal.
- step (C) of the process the adsorption of the nucleic acids is carried out on the same ion exchange surface as that used in step (A) (first active surface), which is a surface exchange surface. anion.
- the adsorption is carried out on a second active surface, corresponding to an anion exchange surface useful for this nucleic acid adsorption step (C), a prelude to the purification and concentration of nucleic acids.
- This second anionic active surface can contain groups bearing different lengths of carbon chains, C 1 -C 18 for example, but also of silica, DNA, RNA I 1 and synthetic analogue of nucleic acids such as PNA and LNA.
- the second active surface is the same anion exchange surface as used in step (A).
- the second surface used may rest on a support and said second active surface and its support may be fixed or movable.
- the method may comprise an optional step (C1), following step (C), of washing purification of the adsorbed nucleic acids.
- This step (C1) is carried out by adding a salt-based solution with preferably, but not necessarily, alcohol in well-defined concentrations, depending on the active surface; it allows the elimination of many chemical and biological contaminants, such as sugars, proteins, lipids, small RNAs, so that only the DNAs and most of the RNAs remain. sample.
- a salt-based solution with preferably, but not necessarily, alcohol in well-defined concentrations, depending on the active surface; it allows the elimination of many chemical and biological contaminants, such as sugars, proteins, lipids, small RNAs, so that only the DNAs and most of the RNAs remain. sample.
- the method according to the invention may also comprise a nucleic acid elution step (C2) following step (C) or step (C1).
- this step (C2) can allow the separation of DNAs and RNAs.
- the retained RNA can be selectively eluted with a saline solution of lower concentration than that required for DNA.
- the elution is carried out by modifying the surface charge of the active surfaces, either by varying the pH and / or by varying the ion concentration. in ranges of concentrations compatible with biochemical and biological reactions, according to methods known to those skilled in the art.
- the overall process for preparing nucleic acids on active anion exchange surfaces is particularly well suited to devices of the laboratory-on-a-chip type.
- the surface capture makes it possible to envisage a very significant downscaling as soon as the first steps of the sample processing are carried out.
- the sample of interest will ultimately be circumscribed to the capture surface, overall the microorganisms and / or DNA and / or RNA will ultimately be stored in a two-dimensional structure, that is to say surface, instead of being stored in solution in a three-dimensional reservoir.
- the invention can be declined in several variants, in particular, subsequent steps of sample processing can be added.
- the step (D) of capturing the nucleic acids on an active surface can be carried out under physicochemical conditions adapted to the type of active surfaces.
- the active surface is incubated with a saline concentration solution of less than 0.8 M NaCl, preferentially less than
- the method according to the invention can be further completed by a step (E) of purification of said nucleic acids.
- This step (E) of purifying the nucleic acids is carried out by passing a washing solution via the incubation of the active surface with a solution based on salts, preferably of composition: 0.5M NaCl, tris-HCl 10 mM, 15% (v / v) ethanol, pH 8 for a PEI type surface or via incubation of the active surface with a salt-based solution, preferably of composition: 2 mM NaCl, 5 mM EDTA, 80% ethanol (y N), pH 7.0.
- a washing solution via the incubation of the active surface with a solution based on salts, preferably of composition: 0.5M NaCl, tris-HCl 10 mM, 15% (v / v) ethanol, pH 8 for a PEI type surface or via incubation of the active surface with a salt-based solution, preferably of composition: 2 mM NaCl, 5 mM EDTA, 80% ethanol (y N), pH 7.0.
- the method may further include a final concentration step (F) via a drying step of removing residual liquids followed by elution to a small volume of liquid.
- step (F) elution of nucleic acids in small volume is carried out by a solution promoting the separation of nucleic acids from the active surface, according to the same principles as those described in (A2); with, preferably, the incubation of the active surface with a NaOH solution not exceeding 100 mM, preferably 50 mM, for 20 seconds at room temperature, for an active surface of the PEI type, or the incubation of the active surface with a 10 mM Tris-HCl solution at 60 ° C. for 2 minutes for a silanol surface.
- the invention relates to a liquid sample treatment device capable of containing microorganisms, characterized in that it contains at least one ion exchange surface, preferably anion, such as as defined above arranged in a chamber such that the ratio of said active surface per unit volume of sample that can be contained in said chamber is between 1 and 200 m 2 / l, preferably between 9 and 100 m 2 / l.
- the device comprises a laboratory on a chip consisting of moving balls supporting the active surfaces.
- the optimal inter-ball distance for the microorganism capture step is about 10 ⁇ m. This distance is also optimal for the capture of nucleic acids.
- the developed surfaces given per unit volume based on kinetic studies of capture of microorganisms Correspond well to the experimental data obtained.
- the surface area per unit volume (S / V) ratio of the chamber through which the sample will pass is calculated with the value of the active area ion exchange present in the chamber and the value of the sample volume that may be contained in the chamber;
- the volume of sample that may be contained in the capture chamber and - the flow rate of the sample.
- Each input data influences the other two.
- the volume of said chamber is 1 .mu.l
- the surface of the two rectangles (20 mm x 5 mm) 200.10 "6 m 2
- the SA / ratio is 200 m 2 / l, which is in the state very greater than the active surface developed by the 1 ⁇ m beads used in the description of the process which follows and can therefore bring even more efficiency to the process.
- the active surface can be further increased by adding a structuring of the chamber, for example by pillars, or a parallelization of the fluidic circuits.
- the adsorption rates should be very fast and therefore allow high flow rates.
- Suitable dimensioning and structuring of the chambers containing the active surface in contact with the liquid sample must therefore make it possible to treat sample volumes with, at least, the same performances as those described in the examples presented below.
- Figure 1 there is described a method of preparing nucleic acids according to the invention for microorganisms present in liquid samples.
- the dashed arrows represent possible steps, or alternative possibilities of sample processing, the term "AN" means nucleic acids.
- the path combinations shown in the figure are as many variants of possible sample preparations.
- This invention finds application in very varied fields: - all the biological analyzes where the elements sought are very diluted and where the whole of the sample must be analyzed;
- This sample preparation method described in the present invention offers several advantages: the simple and generic capture of microorganisms without distinction of sizes; capture of microorganisms and their constituents even at very low concentrations; the capture of microorganisms and their constituent even very concentrated; capture of poorly concentrated microorganisms in a high concentration of total biomass; the preparation of a liquid sample with a high concentration of microorganisms making the process incorporable in standard devices lab-on-a-chip; capturing and continuously concentrating the liquid sample, which may be the whole sample or a modified or unmodified fraction of the whole sample; the possibility of purifying captured microorganisms; the ability to elute and regenerate active surfaces to process large volumes of samples (modified fractions or not); • the possibility of lysing microorganisms in the presence of the active surface; "Capture and purification of nucleic acids;
- FIG. 1 presents a general flowchart detailing the different steps of the method according to the present invention, it is the method implemented in example 1.
- Figure 2 details the capture and regeneration performance of the active surfaces according to the invention.
- Figure 3 shows the capacity in terms of purification yield of DNA or RNA samples according to the nature of the surfaces used, reference to a commercial process.
- Figure 4 shows the detection of model microorganisms used after capture.
- Example 1 Process for preparing nucleic acids 1. Materials and methods
- the method according to the invention was tested during the preparation of nucleic acids from model microorganisms, here Escherischia coli and Bacillus subtilis for vegetative bacterial forms, Bacillus subtilis for sporulated bacterial forms, human adenovirus type 2 (group C) for viruses, Cryptospomoidium parvum for protozoa, and using polyethyleneimine coated (PEI) coated active surface for capture - concentration and purification of microorganisms, and possibly nucleic acids, and silanol for nucleic acids.
- model microorganisms here Escherischia coli and Bacillus subtilis for vegetative bacterial forms
- Bacillus subtilis for sporulated bacterial forms
- human adenovirus type 2 (group C) for viruses
- Cryptospomoidium parvum for protozoa
- PEI polyethyleneimine coated
- the experimental protocol is generically described for all the microorganisms tested.
- a liquid sample of 10 milliliters is previously collected, it may be the whole sample, modified, for example by a treatment such as an ultrafiltration or not, or a fraction of the total sample, modified for example by a treatment such as whether ultrafiltration or not.
- This sample is contacted with an active surface of polyethylene imine (PEI), here 9.2 rVVIitre sample, and supported by super paramagnetic beads of a micrometer diameter (Chemicell).
- PEI polyethylene imine
- the contacting is carried out for 10 minutes with stirring using a vortex, in order to keep the beads well dispersed, and at room temperature.
- the beads are collected using a magnet until clarification of the sample and the liquid phase is eliminated.
- step (B) the beads, containing on their surface the microorganisms, are subjected to a lysis step to allow the opening of said microorganisms and the release of nucleic acids.
- microorganisms adsorbed to the beads are purified by 500 ⁇ l of a solution of NaCl 0.5M, Tris-HCl 10 m M 1 15% ethanol (v / v), pH 8, 0, before being lysed (A1).
- the purified microorganisms are eluted with a solution of 100 mM NaOH at ambient temperature for 2 minutes and then separated from the active surface (here supported by the beads) to be stored (A2).
- the active surface can be regenerated by addition of NaOH to 100 mM and then deionized water, and return to the initial capture step (A3).
- Lyse under "low knows” conditions The lysis of the microorganisms is carried out in the presence of the active surface supported by the beads, contained in 200 ⁇ l of a solution of 50 mM Tris-HCl, 50 mM NaCl, EDTA at 5 mM M, pH 7.5 called "low knows”.
- the beads may be contained in 200 ⁇ l of a solution of 4M NaCl, 50 mM Tris-HCl, 5 mM EDTA, 0.1% sarcosyl, pH 8.5 called "high know. Lysis is performed by ultrasonication.
- the lysis is performed by two successive enzymatic digestions (with lysozyme and proteinase K), as described above. 1 C. Protocol of step (C)
- the beads that adsorbed the nucleic acids are collected and the aqueous phase removed.
- the PEI-adsorbed nucleic acids are purified with 0.5M 1 NaCl solution of 10 mM Tris-HCl, 15% ethanol (v / v), pH 8.0 according to step (C1).
- the beads are collected and the purification solution evacuated.
- the nucleic acids are then eluted by incubating the PEI beads in 100 ⁇ l of a 100 mM NaOH solution at room temperature for 10 seconds.
- the beads are collected, the nucleic acids recovered and the 100 mM NaOH solution neutralized by adding 100 ⁇ l of a 100 mM HCl solution according to step (C2).
- the nucleic acids in solution are then brought into contact with the active surface, here 1, 18 m 2 / l of sample, for 30 seconds with stirring at room temperature, according to (D).
- the beads are collected and the aqueous phase removed.
- a purification step according to (E) is performed by incubation of the beads in a solution of 0.5M NaCl 1 Tris-HCl 10 mM, ethanol 15% (v / v), pH 8.0. Finally, an elution step is carried out with 2 to 10 ⁇ l of a solution of 100 mM NaOH at room temperature for 10 seconds.
- the beads are collected, the supernatant recovered and neutralized by adding the same volume of HCl to 100 mM, according to step (F)
- the nucleic acids eluted from the PEI beads at the end of the lysis stage and neutralized can be mixed with 5 volumes of solution.
- Balls of one micrometer in diameter developing a silanol active surface area of 9.2 m 2 / l of sample are then added according to (D).
- the beads are collected, the aqueous phase removed.
- the adsorbed nucleic acids are purified twice by adding 500 ⁇ l of a 2 mM NaCl solution, 10 mM Tris-HCl, 75% (v / v) ethanol, according to (E).
- the beads are collected, the aqueous phase removed.
- the nucleic acids are then eluted in 5 to 10 ⁇ l of Tris-HCl at 10 mM, pH 8.0 with stirring and at 60 ° C., according to step (F).
- 1-C.2. "High knows” conditions In the case of a lysis performed under "high knows” conditions, the experimenter collects the beads that adsorbed the nucleic acids and recovers the aqueous phase that he mixes with 5 volumes of Guanidine HCl solution. 3M, 20 mM Tris-HCl, 80% (v / v) ethanol pH 4.5. Balls of one micrometer in diameter developing a silanol active surface of 0.92 m 2 / l of sample are then added according to (D).
- the beads are collected, the aqueous phase removed.
- the adsorbed nucleic acids are purified twice by adding 500 ⁇ l of a 2 mM NaCl solution, 10 mM Tris-HCl, 75% (v / v) ethanol, according to step (E). ).
- the beads are collected, the aqueous phase removed.
- the nucleic acids are then eluted in 5 to 10 .mu.l of 10 mM Tris-HCl, pH 8.0 with stirring and at 60.degree. C., according to the principle of concentration in a very small volume of step (F).
- Table III summarizes the elution results of model microorganisms ( ⁇ for Bacillus subtilis, E. c for Escherichia coli, Cp for Cryptospomoidium parvum and Ad2 for human Adenovirus type 2). Solutions used L-Og 10 reduction
- the most favorable condition for elution is an incubation in a solution of 100 mM NaOH, performed here by incubating the active surfaces for 2 minutes at room temperature (25 ° C.) and with stirring (650 rpm).
- This graph shows, on 3 separate samples, that the capture of N microbial elements is perfectly possible by the capture of N / 10 microbial elements repeated 10 times.
- NAs Nucleic acids
- the ANs eluted at the end of each of the two variants were purified once again on a Qiagen column dedicated to either the purification of DNA or of RNA on a silica column.
- the amount of RNA or DNA was measured spectrophotometrically and the yield calculated relative to the reference.
- the graph of Figure 3 shows that the sample preparation method described herein allows for good purification of nucleic acids (NAs), in particular by using the same ion exchange surface to capture both microorganisms and viruses. nucleic acids.
- the graph of Figure 4 shows the detection of nucleic acids of model microorganisms by PCR.
- the initial copy number is doubled.
- the increase in the number of copies is monitored in real time by measuring the specific increase in fluorescence released during the reaction.
- the Ct is directly proportional to the concentration of targets in the amplification reaction medium and corresponds to the first cycle of the linear phase of the amplification.
- the method described has been optimized with magnetic beads as support for active surfaces dedicated to the capture of microorganisms and nucleic acids. It has been validated on recognized model microorganisms: gram-negative and gram-positive bacteria, sporulated bacteria, viruses and protozoa.
- the device comprises:
- a peristaltic pump to allow the displacement of the sample and of all the liquid reagents;
- - a magnet, which allows the collection of magnetic beads;
- a heating ultrasound device which allows the resuspension of the beads collected by the magnet and the opening of the microorganisms;
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0804039A FR2933989B1 (en) | 2008-07-16 | 2008-07-16 | PROCESS FOR PURIFYING MICROORGANISMS IN LIQUID SAMPLES |
PCT/FR2009/000872 WO2010007255A2 (en) | 2008-07-16 | 2009-07-16 | Method for purifying nucleic acids from microorganisms present in liquid samples |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2318539A2 true EP2318539A2 (en) | 2011-05-11 |
Family
ID=40293279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09784273A Withdrawn EP2318539A2 (en) | 2008-07-16 | 2009-07-16 | Method for purifying nucleic acids from microorganisms present in liquid samples |
Country Status (4)
Country | Link |
---|---|
US (1) | US20120009560A1 (en) |
EP (1) | EP2318539A2 (en) |
FR (1) | FR2933989B1 (en) |
WO (1) | WO2010007255A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5899731B2 (en) * | 2011-09-13 | 2016-04-06 | ソニー株式会社 | Nucleic acid purification method, nucleic acid extraction method, and nucleic acid purification kit |
CN108079976B (en) * | 2017-12-07 | 2020-10-16 | 辽宁科技大学 | Preparation method of nano hydroxyapatite/poly (diallyldimethylammonium chloride)/silica gel composite material |
PE20210658A1 (en) | 2018-02-02 | 2021-03-31 | Boehringer Ingelheim Int | TRIAZOLOPYRIMIDINE DERIVATIVES FOR USE AS GHRELIN O-ACILTRANSFERASE (GOAT) INHIBITORS |
JOP20200190A1 (en) | 2018-02-02 | 2020-07-29 | Boehringer Ingelheim Int | Benzyl-, (pyridin-3-yl)methyl- or (pyridin-4-yl)methyl-substituted oxadiazolopyridine derivatives as ghrelin o-acyl transferase (goat) inhibitors |
CN111304289B (en) * | 2020-02-21 | 2023-06-20 | 金陵科技学院 | DNA template preparation liquid and DNA template preparation method |
EP4153600B1 (en) | 2020-05-22 | 2024-08-07 | Boehringer Ingelheim International GmbH | Continuous process for manufacturing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine-carboxylate |
JP2023526351A (en) | 2020-05-22 | 2023-06-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Method for producing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine carboxylate |
WO2024006339A1 (en) * | 2022-06-28 | 2024-01-04 | Research Foundation Of The City University Of New York | Method for purifying a pathogen genome sample |
CN117568143B (en) * | 2024-01-15 | 2024-03-22 | 山东省海洋科学研究院(青岛国家海洋科学研究中心) | Deep sea sample nucleic acid in-situ digestion and preservation device |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6402917B1 (en) * | 1998-02-09 | 2002-06-11 | Otv Societe Anonyme | Electrodialysis apparatus |
CN104591338A (en) * | 2013-11-02 | 2015-05-06 | 四川宝英光电有限公司 | Wastewater purifier for recovering chromic acid |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5112736A (en) * | 1989-06-14 | 1992-05-12 | University Of Utah | Dna sequencing using fluorescence background electroblotting membrane |
DE4034036C2 (en) * | 1990-10-26 | 1994-03-03 | Diagen Inst Molekularbio | Device and method for isolating nucleic acids from cell suspensions |
US5500356A (en) * | 1993-08-10 | 1996-03-19 | Life Technologies, Inc. | Method of nucleic acid sequence selection |
ZA958717B (en) * | 1995-10-16 | 1996-07-31 | Duckstreet Mining Private Limi | Process for purifying cyanide-containing effluent |
WO2003070898A2 (en) * | 2002-02-19 | 2003-08-28 | Choicepoint Asset Company | Selective extraction of dna from groups of cells |
US7597936B2 (en) * | 2002-11-26 | 2009-10-06 | University Of Utah Research Foundation | Method of producing a pigmented composite microporous material |
US20060078923A1 (en) * | 2003-04-02 | 2006-04-13 | Mckernan Kevin | Method for isolating nucleic acids |
US20050106602A1 (en) * | 2003-11-17 | 2005-05-19 | Hashem Akhavan-Tafti | Simplified methods for isolating nucleic acids from cellular materials |
KR100773542B1 (en) * | 2005-07-19 | 2007-11-07 | 삼성전자주식회사 | A microfluidic device for electrochemically regulating the pH of a fluid therein and method for regulating the pH of a fluid in a microfuidic device using the same |
EP1808697A1 (en) * | 2006-01-13 | 2007-07-18 | Novartis Vaccines and Diagnostics, Inc. | Use of an ion exchange matrix for determining the concentration of virus particles and/or virus antigens |
-
2008
- 2008-07-16 FR FR0804039A patent/FR2933989B1/en active Active
-
2009
- 2009-07-16 EP EP09784273A patent/EP2318539A2/en not_active Withdrawn
- 2009-07-16 WO PCT/FR2009/000872 patent/WO2010007255A2/en active Application Filing
- 2009-07-16 US US13/054,294 patent/US20120009560A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6402917B1 (en) * | 1998-02-09 | 2002-06-11 | Otv Societe Anonyme | Electrodialysis apparatus |
CN104591338A (en) * | 2013-11-02 | 2015-05-06 | 四川宝英光电有限公司 | Wastewater purifier for recovering chromic acid |
Also Published As
Publication number | Publication date |
---|---|
WO2010007255A2 (en) | 2010-01-21 |
FR2933989B1 (en) | 2013-03-08 |
US20120009560A1 (en) | 2012-01-12 |
FR2933989A1 (en) | 2010-01-22 |
WO2010007255A3 (en) | 2010-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2318539A2 (en) | Method for purifying nucleic acids from microorganisms present in liquid samples | |
Lim et al. | Current and developing technologies for monitoring agents of bioterrorism and biowarfare | |
EP2433130A2 (en) | Device and method for isolating biological or chemical targets | |
Straub et al. | Automated methods for multiplexed pathogen detection | |
US20070125942A1 (en) | Apparatuses, systems and methods for isolating and separating biological materials | |
Ramadan et al. | Microfluidic applications of functionalized magnetic particles for environmental analysis: focus on waterborne pathogen detection | |
EP2588863B1 (en) | Capture of micro-organisms | |
CA2304846C (en) | Lysis method for micro-organisms | |
CN103702736A (en) | Filtering devices comprising clay minerals | |
CN101503734A (en) | Biomolecular high-sensitivity detecting method | |
Baek et al. | A microfluidic system for the separation and detection of E. coli O157: H7 in soil sample using ternary interactions between humic acid, bacteria, and a hydrophilic surface | |
Yan et al. | Ultrasensitive quantification of pathogens in milliliters of beverage by filtration-based digital LAMP | |
Taguchi et al. | Detection of Cryptosporidium parvum oocysts using a microfluidic device equipped with the SUS micromesh and FITC‐labeled antibody | |
Kim et al. | Biosorption of sub-micron-sized polystyrene microplastics using bacterial biofilms | |
Li et al. | One-stop extraction and in situ RT-qPCR for ultrasensitive detection of highly diluted SARS-CoV-2 in large-volume samples from aquatic environments | |
KR20060109254A (en) | Cell separation method using hydrophobic solid supports | |
US20090093036A1 (en) | Method for releasing genetic material from solid phase | |
Kubota et al. | Cell adsorption and selective desorption for separation of microbial cells by using chitosan-immobilized silica | |
EP1412470B1 (en) | Automated process for detecting pathogenic organisms in water | |
Kastania et al. | Poly-L-histidine coated microfluidic devices for bacterial DNA purification without chaotropic solutions | |
Cady et al. | Micro-and nanotechnology-based approaches to detect pathogenic agents in food | |
EP1728074B1 (en) | Method for extracting intracellular complexes or compounds from a sample containing cells in a liquid suspension | |
Rani et al. | Detection and removal of pathogenic bacteria from wastewater using various nanoparticles | |
KR20070018351A (en) | Method for DNA purification using bare surface of SiO2 structure,and Purification Apparatus thereby | |
Hanif et al. | Pathogens detection and identification in drinking water |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20110215 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: JARY, DOROTHEE Inventor name: COUPE, STEPHANE |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20140224 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20161018 |